Sort
261,768 grants matching “gene therapy”
Towards targeting the lymphoma microenvironment
$908,577Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$908,412James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Vaccine and radiation for the therapy of human cancers
$908,412James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Molecular Mechanisms Of Glaucoma
$908,359Stanislav I Tomarev · National Eye Institute · ZIA · FY2017 · EY
THE PHARMACODYNAMICS OF GENES AND OLIGONUCLEOTIDES
$908,329University Of North Carolina Chapel Hill · P01 · FY2002 · GM
Urology Chronic Pelvic Pain Longitudinal Symptom Patterns Study
$908,112Karl J Kreder · University Of Iowa · U01 · FY2016 · DK
Tie2-driven vascular control in critical illness
$907,996Samir M Parikh · Ut Southwestern Medical Center · R35 · FY2024 · HL
Natural History of Familial Carcinoid Tumor
$907,898Stephen Wank · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Targeting Lewy Body Specific Pathology Using Biomarkers
$907,896Karen S Marder · Columbia University Health Sciences · U01 · FY2020 · NS
Genetic and Molecular Epidemiology of Adult Glioma
$907,868Margaret R. Wrensch · University Of California, San Francisco · R01 · FY2010 · CA
Center for Fetal Gene Transfer for Heart, Lung, and Blood Diseases
$907,868Alice F Tarantal · University Of California At Davis · R24 · FY2008 · HL
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
$907,845Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2012 · CA
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$907,829Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
MTR1: A Dinucleotide Substrate Enhancement and Molecular ByPass Therapy for Thymidine Kinase 2 Deficiency
$907,760Curtis Cui · Mitorainbow Therapeutics, Inc. · R44 · FY2022 · GM
Psychobiology And Treatment Of Perimenopausal Mood Disorders
$907,756Peter J Schmidt · National Institute Of Mental Health · Z01 · FY2007 · MH
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$907,746David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Dynamic regulatory network models of human response to influenza virus
$907,705Ivan Marazzi · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · AI
Tissue mechanics reprograms the tissue to malignancy and metastasis
$907,698Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2024 · CA
CD180 targeted immunotherapeutic for chronic HBV in HIV infected patients
$907,661Deborah L. Fuller · University Of Washington · R56 · FY2019 · AI
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
$907,543Daniel Hal Solomon · Brigham And Women'S Hospital · P30 · FY2017 · AR
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
$907,453Mohamed Abdel Mohsen · Wistar Institute · R01 · FY2020 · NS
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
$907,386Michael David Alpert · Emmune, Inc · R44 · FY2022 · AI
Development of a WNT Inhibitor for Advanced Stage Lung Cancer
$907,344Darren Orton · Stemsynergy Therapeutics, Inc. · R44 · FY2015 · CA
NanoSPECT/CT for Oncology Research
$907,340Pat B Zanzonico · Sloan-Kettering Inst Can Research · S10 · FY2011 · RR
Core B: GMP Cell and RNA Manufacturing
$907,314Bruce L. Levine · University Of Pennsylvania · P01 · FY2018 · CA